E- Corbevax 2nd Made-In-India vaccine

  • The government has booked 30 crore doses of Hyderabad-based Biological-E's Covid vaccine, which is still in clinical trials. 
  • The Health Ministry will make an advance payment of ₹ 1,500 crore to the company for what will be the second made-in-India vaccine to be used in the country after Bharat Biotech's Covaxin. 

CORBEVAX

  • Corbevax is a “recombinant protein sub-unit” vaccine, which means it is made up of a specific part of SARS-CoV-2 — the spike protein on the virus’s surface. 
  • The spike protein allows the virus to enter the cells in the body so that it can replicate and cause disease. 
  • However, when this protein alone is given to the body, it is not expected to be harmful as the rest of the virus is absent. 
  • The body is expected to develop an immune response against the injected spike protein. 
  • Therefore, when the real virus attempts to infect the body, it will already have an immune response ready that will make it unlikely for the person to fall severely ill. 
  • Although this technology has been used for decades to make hepatitis B vaccines, Corbevax will be among the first Covid-19 vaccines to use this platform.
  • Like most other Covid-19 vaccines, Corbevax is administered in two doses.

HOW CORBEVAX IS DIFFERENT?

  • Other Covid-19 vaccines approved so far are either mRNA vaccines (Pfizer and Moderna), Viral vector vaccines (AstraZeneca-Oxford/Covishield, Johnson & Johnson and Sputnik V) or Inactivated vaccines (Covaxin, Sinovac-CoronaVac and Sinopharm’s SARS-CoV-2 Vaccine–Vero Cell).
  • On the other hand, Corbevax, like the mRNA and viral vector Covid-19 vaccines, targets only the spike protein, but in a different way. 
  • Viral vector and mRNA and vaccines use a code to induce our cells to make the spike proteins against which the body have to build immunity. 
  • In the case of Corbevax, the protein is actually being used. 

BIOLOGICAL E

  • Biological E, headquartered in Hyderabad, was founded by Dr D V K Raju in 1953 as a biological products company. 
  • It pioneered the production of heparin in India. 
  • By 1962, it forayed into the vaccines space, producing DPT vaccines on a large-scale.




Comments

Popular posts from this blog

Hamas V. PLO

G7 global corporate Tax Deal

The statue of Swami Vivekananda at the JNU campus